
TECX Valuation
Tectonic Therapeutic Inc
- Overview
- Forecast
- Valuation
- Earnings
TECX Relative Valuation
TECX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TECX is overvalued; if below, it's undervalued.
Historical Valuation
Tectonic Therapeutic Inc (TECX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.02. The fair price of Tectonic Therapeutic Inc (TECX) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:25.39
Fair
-5.16
PE
1Y
3Y
5Y
Trailing
Forward
-1.88
EV/EBITDA
Tectonic Therapeutic Inc. (TECX) has a current EV/EBITDA of -1.88. The 5-year average EV/EBITDA is -0.49. The thresholds are as follows: Strongly Undervalued below -2.17, Undervalued between -2.17 and -1.33, Fairly Valued between 0.35 and -1.33, Overvalued between 0.35 and 1.19, and Strongly Overvalued above 1.19. The current Forward EV/EBITDA of -1.88 falls within the Undervalued range.
-1.65
EV/EBIT
Tectonic Therapeutic Inc. (TECX) has a current EV/EBIT of -1.65. The 5-year average EV/EBIT is -3.46. The thresholds are as follows: Strongly Undervalued below -7.53, Undervalued between -7.53 and -5.49, Fairly Valued between -1.43 and -5.49, Overvalued between -1.43 and 0.60, and Strongly Overvalued above 0.60. The current Forward EV/EBIT of -1.65 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
Tectonic Therapeutic Inc. (TECX) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
-5.73
P/OCF
Tectonic Therapeutic Inc. (TECX) has a current P/OCF of -5.73. The 5-year average P/OCF is -5.75. The thresholds are as follows: Strongly Undervalued below -11.54, Undervalued between -11.54 and -8.65, Fairly Valued between -2.86 and -8.65, Overvalued between -2.86 and 0.03, and Strongly Overvalued above 0.03. The current Forward P/OCF of -5.73 falls within the Historic Trend Line -Fairly Valued range.
-5.29
P/FCF
Tectonic Therapeutic Inc. (TECX) has a current P/FCF of -5.29. The 5-year average P/FCF is -6.00. The thresholds are as follows: Strongly Undervalued below -10.09, Undervalued between -10.09 and -8.04, Fairly Valued between -3.95 and -8.04, Overvalued between -3.95 and -1.90, and Strongly Overvalued above -1.90. The current Forward P/FCF of -5.29 falls within the Historic Trend Line -Fairly Valued range.
Tectonic Therapeutic Inc (TECX) has a current Price-to-Book (P/B) ratio of 1.59. Compared to its 3-year average P/B ratio of 2.38 , the current P/B ratio is approximately -33.23% higher. Relative to its 5-year average P/B ratio of 2.38, the current P/B ratio is about -33.23% higher. Tectonic Therapeutic Inc (TECX) has a Forward Free Cash Flow (FCF) yield of approximately -14.52%. Compared to its 3-year average FCF yield of -13.36%, the current FCF yield is approximately 8.68% lower. Relative to its 5-year average FCF yield of -13.36% , the current FCF yield is about 8.68% lower.
1.59
P/B
Median3y
2.38
Median5y
2.38
-14.52
FCF Yield
Median3y
-13.36
Median5y
-13.36
Competitors Valuation Multiple
The average P/S ratio for TECX's competitors is 0.75, providing a benchmark for relative valuation. Tectonic Therapeutic Inc Corp (TECX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap

TECX.O
Tectonic Therapeutic Inc
Loss
Average P/S: 0.75
475.19M

IMXI.O
International Money Express Inc
0.68
-6.06%
431.01M

SBC.O
SBC Medical Group Holdings Inc
2.24
-18.35%
439.42M

RPAY.O
Repay Holdings Corp
1.45
0.96%
474.14M

CNDT.O
Conduent Inc
0.12
-8.94%
399.67M

RHLD.O
Resolute Holdings Management Inc
Loss
10.16%
487.09M
Performance Decomposition
1Y
3Y
5Y
Market capitalization of TECX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of TECX in the past 1 year is driven by Unknown.
People Also Watch

CGEM
Cullinan Therapeutics Inc
7.670
USD
+2.68%

SLP
Simulations Plus Inc
13.770
USD
-1.92%

CTO
CTO Realty Growth Inc
16.630
USD
0.00%

CLMB
Climb Global Solutions Inc
117.650
USD
+1.20%

CCRN
Cross Country Healthcare Inc
13.590
USD
-1.16%

WEST
Westrock Coffee Co
6.200
USD
-0.48%

RGR
Sturm Ruger & Company Inc
34.020
USD
-0.29%

CTLP
Cantaloupe Inc
10.880
USD
+0.09%
FAQ

Is Tectonic Therapeutic Inc (TECX) currently overvalued or undervalued?
Tectonic Therapeutic Inc (TECX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.02. The fair price of Tectonic Therapeutic Inc (TECX) is between to according to relative valuation methord.

What is Tectonic Therapeutic Inc (TECX) fair value?

How does TECX's valuation metrics compare to the industry average?

What is the current P/B ratio for Tectonic Therapeutic Inc (TECX) as of Aug 22 2025?

What is the current FCF Yield for Tectonic Therapeutic Inc (TECX) as of Aug 22 2025?

What is the current Forward P/E ratio for Tectonic Therapeutic Inc (TECX) as of Aug 22 2025?
